GLP-1 receptor agonists help lower blood glucose levels, which can directly benefit patients with diabetic retinopathy by reducing the likelihood of further damage to the retinal blood vessels
Report worsening mood, new psychiatric symptoms, or severe digestive issues to your doctor immediately
The votes are nonbinding, but they amount to a rebuke of the FDAs own scientists who said the drugs have not been studied enough to know whether they are safe or effective, reports The New York Times
Further investigations indicated that the age of patients with type 2 diabetes does not affect the glycemic efficacy of oral semaglutide and the presence of upper gastrointestinal disease, or that hepatic impairment did not affect the pharmacokinetics of semaglutide [61]
Sustersik, E.A
Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, et al